100 filings
8-K
EPZM
Epizyme, Inc.
12 Aug 22
Termination of a Material Definitive Agreement
12:00pm
8-K
EPZM
Epizyme, Inc.
9 Aug 22
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
7:12am
8-K
EPZM
Epizyme, Inc.
27 Jun 22
Ipsen to acquire Epizyme, expanding its portfolio in oncology
6:14am
8-K
EPZM
Epizyme, Inc.
24 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
EPZM
Epizyme, Inc.
19 May 22
Departure of Directors or Certain Officers
7:57am
8-K
7smt 4jiy4
10 May 22
Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update
7:09am
8-K
cvhpzntwtawd8z7b
6 Apr 22
Departure of Directors or Certain Officers
5:00pm
8-K
4p0ikfliirj3h7oz3wb7
15 Mar 22
Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update
7:09am
8-K
qnxqk
1 Mar 22
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
7:39am
8-K
6744f2ta4rxkct
27 Jan 22
Entry into a Material Definitive Agreement
5:08pm
8-K
ix68wazkcxckm4 ghn
10 Jan 22
Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full
7:05am
8-K
6uboa1hx
22 Dec 21
Termination of a Material Definitive Agreement
4:05pm
8-K
t9kyajyimx
18 Nov 21
Epizyme Announces Updates to Its Board of Directors
6:42am
8-K
gt0l wi9yyp3
9 Nov 21
Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update
6:39am
8-K
cl17ju
29 Oct 21
Departure of Directors or Certain Officers
6:49am
8-K
ndgx3cxnfen
16 Aug 21
Entry into a Material Definitive Agreement
4:57pm
8-K
jx9qv01qci8u vcx3c
9 Aug 21
Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update
7:41am
8-K
89c5nssv4vded8hm
28 Jun 21
Departure of Directors or Certain Officers
5:20pm
8-K
auinsx1o 973qg
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:55am
8-K
wde72dwla
6 May 21
Epizyme Provides Business Update and Reports First Quarter 2021 Financial Results
6:56am